Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024
Compare Balance Sheet Results of Saroja Pharma In
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.02
0
4.02
0.00%
Share Warrants & Outstandings
Total Reserve
11.66
0
11.66
0.00%
Shareholder's Funds
15.68
0
15.68
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
1.38
0
1.38
0.00%
Secured Loans
0.40
0
0.40
0.00%
Unsecured Loans
0.98
0
0.98
0.00%
Deferred Tax Assets / Liabilities
0.01
0
0.01
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
1.39
0
1.39
0.00%
Current Liabilities
Trade Payables
13.65
0
13.65
0.00%
Other Current Liabilities
0.77
0
0.77
0.00%
Short Term Borrowings
8.08
0
8.08
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
22.49
0
22.49
0.00%
Total Liabilities
39.55
0
39.55
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
2.85
0
2.85
0.00%
Less: Accumulated Depreciation
0.34
0
0.34
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
2.51
0
2.51
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
8.61
0
8.61
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.34
0
0.34
0.00%
Long Term Loans & Advances
0.88
0
0.88
0.00%
Other Non Current Assets
0.00
0
0.00
0.00%
Total Non-Current Assets
12.34
0
12.34
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
0.10
0
0.10
0.00%
Sundry Debtors
26.58
0
26.58
0.00%
Cash and Bank
0.33
0
0.33
0.00%
Other Current Assets
0.16
0
0.16
0.00%
Short Term Loans and Advances
0.05
0
0.05
0.00%
Total Current Assets
27.22
0
27.22
0.00%
Net Current Assets (Including Current Investments)
4.73
0
4.73
0.00%
Total Current Assets Excluding Current Investments
27.22
0
27.22
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
39.55
0
39.55
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
9.46
0
9.46
0.00%
Book Value per share (adjusted)
38.99
0
38.99
0.00%
Annual - Borrowings
Borrowings 9.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 11.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024
Annual - Investments
Investments 0.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024
Annual - Current Assets
Current Assets 27.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024






